इकोनाज़ोल के इंटरैक्शन

हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें इकोनाज़ोल (Spectazole, Ecoza; एज़ोल एंटीफंगल) के 108 इंटरैक्शन दर्ज हैं: 18 गंभीर, 67 मध्यम, 22 मामूली, और 1 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।

लेबल से लिए गए इंटरैक्शन

गंभीर इंटरैक्शन (18)

  • अल्प्राज़ोलमबेंज़ोडायज़ेपिनगंभीर

    Strong CYP3A Inhibitors Alprazolam XR is contraindicated in patients receiving strong inhibitors of CYP3A such as azole antifungal agents [see Contraindications (4) ] . (अल्प्राज़ोलम लेबल, चेतावनियां और सावधानियां)

  • इट्राकोनाज़ोलएज़ोल एंटीफंगलगंभीर

    There is limited information regarding cross-hypersensitivity between itraconazole and other azole antifungal agents [see Warnings and Precautions (5.8) ] . (इट्राकोनाज़ोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • VYTORIN is contraindicated in the following conditions: Concomitant use of strong CYP3A4 inhibitors (select azole anti-fungals, macrolide antibiotics, anti-viral medications, and nefazodone) [see Drug Interactions (7.1) ] . (एज़ेटिमाइब और सिमवास्टेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • एमियोडेरोनएंटीएरिदमिकगंभीर

    Table 5: Amiodarone Drug Interactions Concomitant Drug Class/Name Examples Clinical Comment QT Prolonging Drugs class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents Increased risk of Torsade de Pointes. (एमियोडेरोन लेबल, दवाओं के इंटरैक्शन)

  • एवरोलिमसइम्यूनोसप्रेसेंटगंभीर

    Do not administer antifungal agents, unless fungal infection has been diagnosed. (एवरोलिमस लेबल, चेतावनियां और सावधानियां)

  • कीटोकोनाज़ोलएज़ोल एंटीफंगलगंभीर

    Ketoconazole tablets should be used only when other effective antifungal therapy is not available or tolerated and the potential benefits are considered to outweigh the potential risks. (कीटोकोनाज़ोल लेबल, बॉक्स्ड चेतावनी)

  • TEMODAR is contraindicated in patients with a history of serious hypersensitivity reactions to: temozolomide or any other ingredients in TEMODAR; and dacarbazine, since both temozolomide and dacarbazine are metabolized to the same active metabolite 5-(3-methyltriazen-1-yl)-imidazole-4-carboxamide. (टेमोज़ोलोमाइड लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • डारुनाविरएंटीरेट्रोवायरलगंभीर

    When co-administration is required, the daily dose of ketoconazole or itraconazole should not exceed 200 mg with monitoring for increased antifungal adverse events. voriconazole ↓ voriconazole Voriconazole is not recommended for patients receiving PREZISTA/ritonavir unless an assessment comparing predicted benefit to risk ratio justifies the use of voriconazole. (डारुनाविर लेबल, दवाओं के इंटरैक्शन)

  • तंबाकू और धूम्रपानतंबाकू और कैनाबिसगंभीर

    Instruct the patient to avoid heat, flame, and/or smoking during and immediately following application. (इकोनाज़ोल लेबल, चेतावनियां और सावधानियां)

  • Antifungals voriconazole ↓ voriconazole Avoid concomitant use of voriconazole. ketoconazole, isavuconazonium sulfate, itraconazole ↑ ketoconazole ↑ isavuconazonium sulfate ↑ itraconazole Refer to the ketoconazole, isavuconazonium sulfate, and itraconazole prescribing information for further information. ↑ nirmatrelvir/ritonavir A nirmatrelvir/ritonavir dose reduction… (निर्माट्रेल्विर और रिटोनाविर लेबल, दवाओं के इंटरैक्शन)

  • पिमोज़ाइडएंटीसाइकोटिकगंभीर

    Because azole antifungal agents are also inhibitors of the CYP 3A4 enzymes and thus may likewise impair pimozide metabolism, pimozide is contraindicated in patients receiving the azole antifungal agents itraconazole and ketoconazole. (पिमोज़ाइड लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • पोसाकोनाज़ोलएज़ोल एंटीफंगलगंभीर

    Known hypersensitivity to posaconazole or other azole antifungal agents. (पोसाकोनाज़ोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • फ्लुकोनाज़ोलएज़ोल एंटीफंगलगंभीर

    There is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. (फ्लुकोनाज़ोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • ब्रोमोक्रिप्टिनडोपामिन एगोनिस्टगंभीर

    Concomitant use of strong CYP3A4 inhibitors (e.g., azole antimycotics, HIV protease inhibitors) with CYCLOSET should be avoided. (ब्रोमोक्रिप्टिन लेबल, दवाओं के इंटरैक्शन)

  • रिटोनाविरएंटीरेट्रोवायरलगंभीर

    …Pharmacology ( 12.3 )] . ○ Alpha 1- Adrenoreceptor Antagonist: alfuzosin ○ Antianginal: ranolazine ○ Antiarrhythmics: amiodarone, dronedarone, flecainide, propafenone, quinidine ○ Antifungal: voriconazole ○ Anti-gout: colchicine ○ Antipsychotics: lurasidone, pimozide ○ Ergot Derivatives: dihydroergotamine, ergotamine, methylergonovine ○ GI Motility Agent: cisapride… (रिटोनाविर लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • रिफैम्पिसिनएंटीबायोटिकगंभीर

    …Anticoagulants Prevention or Management: Perform prothrombin time daily or as frequently as necessary to establish and maintain the required dose of anticoagulant Warfarin Decrease exposure Antifungals Fluconazole Decrease AUC by 23% Itraconazole Prevention or Management: Not recommended 2 weeks before and during itraconazole treatment Decrease exposure Ketoconazole Decrease… (रिफैम्पिसिन लेबल, दवाओं के इंटरैक्शन)

  • वोरिकोनाज़ोलएज़ोल एंटीफंगलगंभीर

    There is no information regarding cross-sensitivity between voriconazole and other azole antifungal agents. (वोरिकोनाज़ोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • सिमवास्टेटिनस्टेटिनगंभीर

    ZOCOR is contraindicated in the following conditions: Concomitant use of strong CYP3A4 inhibitors (select azole anti-fungals, macrolide antibiotics, anti-viral medications, and nefazodone) [see Drug Interactions (7.1) ] . (सिमवास्टेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

मध्यम इंटरैक्शन (67)

  • Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase the systemic absorption of econazole nitrate. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase the systemic absorption of econazole nitrate. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase the systemic absorption of econazole nitrate. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • आर्गाट्रोबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • इन्फ्लिक्सिमैबइम्यूनोसप्रेसेंटमध्यम

    Invasive fungal infections – for patients who develop a systemic illness on RENFLEXIS, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic. (इन्फ्लिक्सिमैब लेबल, चेतावनियां और सावधानियां)

  • एटाज़ानाविरएंटीरेट्रोवायरलमध्यम

    Antifungals: ketoconazole, itraconazole REYATAZ with ritonavir: ↑ ketoconazole ↑ itraconazole Coadministration of ketoconazole has only been studied with REYATAZ without ritonavir (negligible increase in atazanavir AUC and C max ). (एटाज़ानाविर लेबल, दवाओं के इंटरैक्शन)

  • एटोरवास्टेटिनस्टेटिनमध्यम

    LIPITOR dosage modifications are recommended for patients taking certain anti-viral, azole antifungals, or macrolide antibiotic medications [see Dosage and Administration (2.5) ] . (एटोरवास्टेटिन लेबल, चेतावनियां और सावधानियां)

  • एट्राविरिनएंटीरेट्रोवायरलमध्यम

    Antifungals : fluconazole ↑ etravirine ↔ fluconazole Co-administration of etravirine and fluconazole significantly increased etravirine exposures. (एट्राविरिन लेबल, दवाओं के इंटरैक्शन)

  • एडालिमुमैबइम्यूनोसप्रेसेंटमध्यम

    • Invasive fungal infections: For patients who develop a systemic illness on Adalimumab-fkjp, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic. (एडालिमुमैब लेबल, चेतावनियां और सावधानियां)

  • एडोक्साबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • एनोक्सापैरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • एपिक्साबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • एफाविरेंज़एंटीरेट्रोवायरलमध्यम

    Antifungals: Voriconazole Itraconazole Ketoconazole Posaconazole ↓ voriconazole * ↑ efavirenz * ↓ itraconazole * ↓ hydroxyitraconazole * ↓ ketoconazole ↓ posaconazole * Efavirenz and voriconazole should not be coadministered at standard doses. (एफाविरेंज़ लेबल, दवाओं के इंटरैक्शन)

  • Antifungals: Itraconazole Ketoconazole ↓ itraconazole ↓ hydroxyitraconazole ↓ ketoconazole Consider alternative antifungal treatment because no dose recommendation for itraconazole or ketoconazole can be made. (एफाविरेंज़, लैमिवुडिन और टेनोफोविर लेबल, दवाओं के इंटरैक्शन)

  • Azole Antifungal Agents: fluconazole itraconazole ketoconazole posaconazole voriconazole ↑ RPV , This interaction study has been performed with a dose higher than the recommended dose for RPV assessing the maximal effect on the coadministered drug. (एमट्रिसिटाबिन, रिल्पिविरिन और टेनोफोविर लेबल, दवाओं के इंटरैक्शन)

  • एम्लोडिपिन और एटोरवास्टेटिनडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमध्यम

    Amlodipine and atorvastatin tablets dosage modifications are recommended for patients taking certain anti-viral, azole antifungals, or macrolide antibiotic medications [see Dosage and Administration (2) ] . (एम्लोडिपिन और एटोरवास्टेटिन लेबल, चेतावनियां और सावधानियां)

  • Antifungals: itraconazole ketoconazole voriconazole ↑ elvitegravir ↑ cobicistat ↑ itraconazole ↑ ketoconazole ↑ voriconazole When administering with GENVOYA, the maximum daily dosage of ketoconazole or itraconazole should not exceed 200 mg per day. (एल्विटेग्राविर, कोबिसिस्टैट, एमट्रिसिटाबिन और टेनोफोविर लेबल, दवाओं के इंटरैक्शन)

  • एस्ट्राडियोल और डायनोजेस्टगर्भनिरोधक गोलीमध्यम

    …[See Clinical Pharmacology (12.3).] Substances Increasing the Systemic Exposure of COCs (enzyme inhibitors): Concomitant administration of moderate or strong CYP3A4 inhibitors like azole antifungals (for example, ketoconazole, itraconazole, voriconazole, fluconazole), verapamil, macrolides (for example, clarithromycin, erythromycin), diltiazem, and grapefruit… (एस्ट्राडियोल और डायनोजेस्ट लेबल, दवाओं के इंटरैक्शन)

  • ऑक्सीकोडोनओपिओइडमध्यम

    …of Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of Oxycodone Hydrochloride Oral Solution with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of oxycodone and prolong opioid adverse reactions, which… (ऑक्सीकोडोन लेबल, चेतावनियां और सावधानियां)

  • …Discontinuation of Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of oxycodone hydrochloride tablets with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of oxycodone and prolong opioid adverse reactions, which… (ऑक्सीकोडोन और पैरासिटामोल लेबल, चेतावनियां और सावधानियां)

  • कोडीनओपिओइडमध्यम

    Cytochrome P450 3A4 Interaction: The concomitant use of Codeine Sulfate Tablets with all cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (कोडीन लेबल, चेतावनियां और सावधानियां)

  • क्लैरिथ्रोमाइसिनमैक्रोलाइड एंटीबायोटिकमध्यम

    Antifungals: Itraconazole Use With Caution Itraconazole: Both clarithromycin and itraconazole are substrates and inhibitors of CYP3A, potentially leading to a bi-directional drug interaction when administered concomitantly (see also Itraconazole under “Drugs That Affect Clarithromycin Tablets” in the table below). (क्लैरिथ्रोमाइसिन लेबल, दवाओं के इंटरैक्शन)

  • ग्रिसियोफुल्विनएंटीफंगलमध्यम

    Barbiturates usually depress griseofulvin activity by decreasing plasma levels and concomitant administration may require a dosage adjustment of the antifungal agent. (ग्रिसियोफुल्विन लेबल, दवाओं के इंटरैक्शन)

  • ग्लिपिज़ाइड और मेटफॉर्मिनसल्फोनिलयूरियामध्यम

    Glipizide: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs, including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta-adrenergic blocking agents. (ग्लिपिज़ाइड और मेटफॉर्मिन लेबल, सावधानियां)

  • टैक्रोलिमसइम्यूनोसप्रेसेंटमध्यम

    Strong CYP3A Inhibitors c : Protease inhibitors (e.g., nelfinavir, telaprevir, boceprevir, ritonavir), azole antifungals (e.g., voriconazole, posaconazole, itraconazole, ketoconazole), antibiotics (e.g., clarithromycin, troleandomycin, chloramphenicol), nefazodone, letermovir, Schisandra sphenanthera extracts May increase tacrolimus whole blood trough concentrations… (टैक्रोलिमस लेबल, दवाओं के इंटरैक्शन)

  • टोल्टेरोडिनएंटीकोलिनर्जिकमध्यम

    For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (e.g., itraconazole, miconazole) or macrolide antibiotics (e.g., erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL is 1 mg twice daily (see DOSAGE AND ADMINISTRATION ). (टोल्टेरोडिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रामाडोलओपिओइडमध्यम

    …P450 3A4 Interaction The concomitant use of Tramadol Hydrochloride Extended-Release Capsules with cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (ट्रामाडोल लेबल, चेतावनियां और सावधानियां)

  • Cytochrome P450 3A4 Interaction The concomitant use of tramadol hydrochloride and acetaminophen with cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (ट्रामाडोल और पैरासिटामोल लेबल, चेतावनियां और सावधानियां)

  • डाइक्लोरफेनामाइडकार्बोनिक एनहाइड्रेज़ इनहिबिटरमध्यम

    Drugs that Cause Hypokalemia The risk of hypokalemia is greater with coadministration of KEVEYIS and other drugs that can cause hypokalemia (e.g., loop diuretics, thiazide diuretics, laxatives, antifungals, penicillins, and theophylline) [see Warnings and Precautions (5.3) ] . (डाइक्लोरफेनामाइड लेबल, दवाओं के इंटरैक्शन)

  • डारुनाविर और कोबिसिस्टैटएंटीरेट्रोवायरलमध्यम

    Tricyclic Antidepressants (TCAs): e.g. amitriptyline, desipramine, imipramine, nortriptyline ↑ TCAs Other antidepressants: trazodone ↑ trazodone Antifungals: itraconazole, isavuconazole, ketoconazole, posaconazole ↑ darunavir ↑ cobicistat Monitor for increased darunavir or cobicistat and/or antifungal adverse reactions. ↑ itraconazole ↑ ketoconazole ↑ isavuconazole… (डारुनाविर और कोबिसिस्टैट लेबल, दवाओं के इंटरैक्शन)

  • डैबिगैट्रानएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • डोफेटिलाइडएंटीएरिदमिकमध्यम

    Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously co-administered with dofetilide as they can potentially increase dofetilide levels. (डोफेटिलाइड लेबल, दवाओं के इंटरैक्शन)

  • Concomitant administration of moderate or strong CYP3A4 inhibitors such as azole antifungals (e.g., ketoconazole, itraconazole, voriconazole, fluconazole), verapamil, macrolides (e.g., clarithromycin, erythromycin), diltiazem, and grapefruit juice can increase the plasma concentrations of the estrogen or the progestin or both. (ड्रोस्पिरेनोन और एथिनिल एस्ट्राडियोल लेबल, दवाओं के इंटरैक्शन)

  • नाइट्रोग्लिसरीननाइट्रेटमध्यम

    Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase the systemic absorption of econazole nitrate. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • निफेडिपिनडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमध्यम

    Non-Cardiovascular Drugs Antifungal Drugs Ketoconazole, itraconazole and fluconazole are CYP3A inhibitors and can inhibit the metabolism of nifedipine and increase the exposure to nifedipine during concomitant therapy. (निफेडिपिन लेबल, सावधानियां)

  • निमोडिपिनडाइहाइड्रोपाइरिडीन कैल्शियम चैनल ब्लॉकरमध्यम

    …clarithromycin, telithromycin), some HIV protease inhibitors (e.g., indinavir, nelfinavir, ritonavir, saquinavir), some HCV protease inhibitors (e.g., boceprevir, telaprevir), some azole antimycotics (e.g., ketoconazole, itraconazole, posaconazole, voriconazole), conivaptan, delavirdine, and nefazodone with nimodipine should generally be avoided because of a risk… (निमोडिपिन लेबल, चेतावनियां और सावधानियां)

  • नेफाज़ोडोनएंटीडिप्रेसेंटमध्यम

    Similarly, there were no changes in the pharmacokinetic parameters of nefazodone or HO-NEF; however, the mean AUC levels of the nefazodone metabolites mCPP and triazole-dione increased by 3 to 6 fold and 1.3 fold, respectively. (नेफाज़ोडोन लेबल, दवाओं के इंटरैक्शन)

  • नेविरापिनएंटीरेट्रोवायरलमध्यम

    Antifungals: Fluconazole ↑ Nevirapine Because of the risk of increased exposure to nevirapine, caution should be used in concomitant administration, and patients should be monitored closely for nevirapine-associated adverse events. (नेविरापिन लेबल, दवाओं के इंटरैक्शन)

  • पेथिडीनओपिओइडमध्यम

    …or Discontinuation of Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of DEMEROL Injection with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of meperidine and prolong opioid adverse reactions, which… (पेथिडीन लेबल, चेतावनियां और सावधानियां)

  • …P450 3A4 Interaction The concomitant use of acetaminophen and codeine phosphate tablets with all cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (पैरासिटामोल और कोडीन लेबल, चेतावनियां)

  • …Interaction The concomitant use of Promethazine HCl and Codeine Phosphate Oral Solution with all cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (प्रोमेथाज़िन और कोडीन लेबल, चेतावनियां और सावधानियां)

  • फेंटानिलओपिओइडमध्यम

    …Discontinuation of Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of Fentanyl Citrate Injection with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of fentanyl and prolong opioid adverse reactions, which may… (फेंटानिल लेबल, चेतावनियां और सावधानियां)

  • फेनिटोइनएंटीकन्वल्सेंट (दौरे की दवा)मध्यम

    …Phenytoin Concentrations Interacting Agent Examples Drugs that may increase phenytoin serum levels Antiepileptic drugs Ethosuximide, felbamate, oxcarbazepine, methsuximide, topiramate Azoles Fluconazole, ketoconazole, itraconazole, miconazole, voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric… (फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

  • फॉस्फेनिटोइनएंटीकन्वल्सेंट (दौरे की दवा)मध्यम

    …Phenytoin Concentrations Interacting Agent Examples Drugs that may increase phenytoin serum levels Antiepileptic drugs Ethosuximide, felbamate, oxcarbazepine, methsuximide, topiramate Azoles Fluconazole, ketoconazole, itraconazole, miconazole, voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric… (फॉस्फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

  • फोंडापैरिनक्सएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • फोसएम्प्रेनाविरएंटीरेट्रोवायरलमध्यम

    Antifungals: Ketoconazole a , itraconazole ↑ Ketoconazole ↑ Itraconazole Increase monitoring for adverse events. (फोसएम्प्रेनाविर लेबल, दवाओं के इंटरैक्शन)

  • फ्लिबैनसेरिनCNS डिप्रेसेंटमध्यम

    Strong CYP2C19 Inhibitors Examples Proton pump inhibitors, selective serotonin reuptake inhibitors, benzodiazepines, antifungals Clinical Implications The concomitant use of ADDYI with strong CYP2C19 inhibitors may increase flibanserin exposure which may increase the risk of hypotension, syncope, and CNS depression. (फ्लिबैनसेरिन लेबल, दवाओं के इंटरैक्शन)

  • बिवालिरुडिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • …Interaction The concomitant use of BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE with all cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (ब्यूटाल्बिटल, एस्पिरिन, कैफीन और कोडीन लेबल, चेतावनियां और सावधानियां)

  • …concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with all cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin,… (ब्यूटाल्बिटल, पैरासिटामोल, कैफीन और कोडीन लेबल, चेतावनियां और सावधानियां)

  • ब्यूप्रेनॉर्फिनओपिओइडमध्यम

    Examples: Macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), protease inhibitors (e.g., ritonavir) CYP3A4 Inducers Clinical Impact: The concomitant use of BELBUCA and CYP3A4 inducers can decrease the plasma concentration of buprenorphine [see Clinical Pharmacology (12.3) ] , potentially resulting in decreased efficacy or… (ब्यूप्रेनॉर्फिन लेबल, दवाओं के इंटरैक्शन)

  • Examples: Macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g. ketoconazole), protease inhibitors (e.g., ritonavir) CYP3A4 Inducers Clinical Impact: The concomitant use of buprenorphine and CYP3A4 inducers can decrease the plasma concentration of buprenorphine [see Clinical Pharmacology (12.3) ] , potentially resulting in decreased efficacy… (ब्यूप्रेनॉर्फिन और नालोक्सोन लेबल, दवाओं के इंटरैक्शन)

  • मेथाडोनओपिओइडमध्यम

    Examples: Macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), protease inhibitors (e.g., ritonavir), fluconazole, fluvoxamine, some selective serotonin reuptake inhibitors (SSRIs) (e.g., sertraline, fluvoxamine) Inducers of CYP3A4, CYP2B6, CYP2C19, or CYP2C9 Clinical Impact: The concomitant use of methadone and CYP3A4, CYP2B6,… (मेथाडोन लेबल, दवाओं के इंटरैक्शन)

  • रिफापेंटिनएंटीबायोटिकमध्यम

    …Antibiotics Chloramphenicol, clarithromycin, dapsone, doxycycline; Fluoroquinolones (such as ciprofloxacin) Oral Anticoagulants Warfarin Anticonvulsants Phenytoin Antimalarials Quinine Azole Antifungals Fluconazole, itraconazole, ketoconazole Antipsychotics Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propranolol Calcium Channel Blockers… (रिफापेंटिन लेबल, दवाओं के इंटरैक्शन)

  • रिफाब्यूटिनएंटीबायोटिकमध्यम

    ANTIFUNGALS Fluconazole 200 mg once a day for 2 weeks 300 mg once a day for 2 weeks HIV-infected patients (12) ↑ AUC by 82%, ↑ C max by 88% ↔ Monitor for rifabutin associated adverse events. (रिफाब्यूटिन लेबल, दवाओं के इंटरैक्शन)

  • रियोसिगुआटवैसोडाइलेटरमध्यम

    Strong CYP and P-gp/BCRP inhibitors: Concomitant use of riociguat with strong cytochrome CYP inhibitors and P-gp/BCRP inhibitors such as azole antimycotics (for example, ketoconazole, itraconazole) or HIV protease inhibitors (such as ritonavir) increase riociguat exposure and may result in hypotension. (रियोसिगुआट लेबल, दवाओं के इंटरैक्शन)

  • रिल्पिविरिनएंटीरेट्रोवायरलमध्यम

    Azole Antifungal Agents: fluconazole itraconazole ketoconazole This interaction study has been performed with a dose higher than the recommended dose for EDURANT assessing the maximal effect on the coadministered drug. (रिल्पिविरिन लेबल, दवाओं के इंटरैक्शन)

  • रिवारोक्साबैनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • लोपिनाविर और रिटोनाविरएंटीरेट्रोवायरलमध्यम

    Antifungals: ketoconazole*, itraconazole, voriconazole isavuconazonium sulfate* ↑ ketoconazole ↑ itraconazole ↓ voriconazole ↑ isavuconazonium High doses of ketoconazole (>200 mg/day) or itraconazole (> 200 mg/day) are not recommended. (लोपिनाविर और रिटोनाविर लेबल, दवाओं के इंटरैक्शन)

  • वारफेरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

  • साइक्लोस्पोरिनइम्यूनोसप्रेसेंटमध्यम

    Drugs That May Potentiate Renal Dysfunction Antibiotics Antineoplastics Antifungals Anti-inflammatory Drugs Gastrointestinal Agents Immunosuppressives Other Drugs ciprofloxacin melphalan amphotericin B azapropazon cimetidine tacrolimus fibric acid derivatives (e.g., bezafibrate, fenofibrate) gentamicin ketoconazole colchicine ranitidine methotrexate tobramycin… (साइक्लोस्पोरिन लेबल, दवाओं के इंटरैक्शन)

  • हाइड्रोकोडोनओपिओइडमध्यम

    …Concomitant Use or Discontinuation of Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of HYSINGLA ER with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone and prolong opioid adverse reactions, which… (हाइड्रोकोडोन लेबल, चेतावनियां और सावधानियां)

  • …Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of Hydrocodone Bitartrate and Ibuprofen Tablets with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone and prolong opioid adverse reactions, which… (हाइड्रोकोडोन और आइबुप्रोफेन लेबल, चेतावनियां)

  • …3A4 Inhibitors and Inducers Concomitant use of Hydrocodone Polistirex and Chlorpheniramine Polistirex with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone and prolong opioid adverse reactions, which… (हाइड्रोकोडोन और क्लोरफेनिरामिन लेबल, चेतावनियां और सावधानियां)

  • …Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of hydrocodone bitartrate and acetaminophen tablets with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone bitartrate and acetaminophen tablets and prolong… (हाइड्रोकोडोन और पैरासिटामोल लेबल, चेतावनियां)

  • …P450 3A4 Inhibitors and Inducers Concomitant use of hydrocodone bitartrate and homatropine methylbromide with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone and prolong opioid adverse reactions, which… (हाइड्रोकोडोन और होमाट्रोपिन लेबल, चेतावनियां और सावधानियां)

  • हेपरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    - 7.1 Warfarin Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. (इकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

मामूली ज़िक्र (22)

  • Examples of strong CYP3A4 inhibitors include azole antifungals (e.g., itraconazole), macrolide antibiotics (e.g., clarithromycin, telithromycin), HIV protease inhibitors (e.g., nelfinavir), and nefazodone. (आइवाब्राडिन लेबल, दवाओं के इंटरैक्शन)

  • एम्फोटेरिसिन Bएंटीफंगलमामूली

    Azoles (e.g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.) In vitro and in vivo animal studies of the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B. (एम्फोटेरिसिन B लेबल, दवाओं के इंटरैक्शन)

  • ओलिसेरिडिनओपिओइडमामूली

    Examples: Macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g. ketoconazole), protease inhibitors (e.g., ritonavir). (ओलिसेरिडिन लेबल, दवाओं के इंटरैक्शन)

  • कार्बामाज़ेपिनएंटीकन्वल्सेंट (दौरे की दवा)मामूली

    The following drugs are CYP3A4 inhibitors: Acetazolamide, aprepitant, azole antifungals (e.g., ketoconazole, itraconazole, fluconazole, voriconazole ) , cimetidine, ciprofloxacin, clarithromycin, dalfopristin, danazol, dantrolene, delavirdine, diltiazem, erythromycin, fluoxetine, fluvoxamine, grapefruit juice, ibuprofen, isoniazid, loratadine, nefazodone, niacinamide,… (कार्बामाज़ेपिन लेबल, दवाओं के इंटरैक्शन)

  • क्लोनाज़ेपामबेंज़ोडायज़ेपिनमामूली

    Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in clonazepam metabolism, inhibitors of this enzyme system, notably oral antifungal agents (e.g., fluconazole), should be used cautiously in patients receiving clonazepam because they may impair the metabolism of clonazepam leading to exaggerated concentrations… (क्लोनाज़ेपाम लेबल, दवाओं के इंटरैक्शन)

  • टिनिडाज़ोलएंटीबायोटिकमामूली

    Vaginal candidiasis may develop with tinidazole and require treatment with an antifungal agent (5.2) (टिनिडाज़ोल लेबल, चेतावनियां और सावधानियां)

  • डाइहाइड्रोएर्गोटामिनएर्गोट एल्कलॉइडमामूली

    Examples of some of the more potent CYP3A4 inhibitors include: antifungals ketoconazole and itraconazole, the protease inhibitors ritonavir, nelfinavir, and indinavir, and macrolide antibiotics erythromycin, clarithromycin, and troleandomycin. (डाइहाइड्रोएर्गोटामिन लेबल, चेतावनियां)

  • डेसोनाइडकॉर्टिकोस्टेरॉइडमामूली

    If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used. (डेसोनाइड लेबल, सावधानियां)

  • फ्लुओसिनोनाइडकॉर्टिकोस्टेरॉइडमामूली

    Concomitant Skin Infections If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used. (फ्लुओसिनोनाइड लेबल, चेतावनियां और सावधानियां)

  • फ्लुटिकासोनकॉर्टिकोस्टेरॉइडमामूली

    When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral) antifungal therapy while treatment with Fluticasone Propionate DISKUS continues, but at times therapy with Fluticasone Propionate DISKUS may need to be interrupted. (फ्लुटिकासोन लेबल, चेतावनियां और सावधानियां)

  • फ्लुटिकासोन और सैल्मेटेरोलकॉर्टिकोस्टेरॉइडमामूली

    When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral) antifungal therapy while treatment with Fluticasone Propionate/Salmeterol MDPI continues, but at times therapy with Fluticasone Propionate/Salmeterol MDPI may need to be interrupted. (फ्लुटिकासोन और सैल्मेटेरोल लेबल, चेतावनियां और सावधानियां)

  • फ्लुसाइटोसिनएंटीफंगलमामूली

    Drug Interactions Cytosine arabinoside, a cytostatic agent, has been reported to inactivate the antifungal activity of ANCOBON by competitive inhibition. (फ्लुसाइटोसिन लेबल, दवाओं के इंटरैक्शन)

  • Development of Potential for Microbial Overgrowth Known or previously unrecognized candidiasis may present more prominent symptoms during therapy with metronidazole and requires treatment with an antifungal agent. (बिस्मथ सबसाइट्रेट, मेट्रोनिडाज़ोल और टेट्रासाइक्लिन लेबल, चेतावनियां और सावधानियां)

  • बुडेसोनाइडकॉर्टिकोस्टेरॉइडमामूली

    When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while treatment with PULMICORT FLEXHALER continues, but at times, therapy with PULMICORT FLEXHALER may need to be interrupted. (बुडेसोनाइड लेबल, चेतावनियां और सावधानियां)

  • बुडेसोनाइड और फॉर्मोटेरोलकॉर्टिकोस्टेरॉइडमामूली

    When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while treatment with budesonide and formoterol fumarate dihydrate continues, but at times therapy with budesonide and formoterol fumarate dihydrate may need to be interrupted. (बुडेसोनाइड और फॉर्मोटेरोल लेबल, चेतावनियां और सावधानियां)

  • बेक्लोमेथासोनकॉर्टिकोस्टेरॉइडमामूली

    If oropharyngeal candidiasis develops, it should be treated with appropriate local or systemic (i.e., oral) antifungal therapy while still continuing with QVAR REDIHALER therapy, but at times therapy with QVAR REDIHALER may need to be temporarily interrupted under close medical supervision. (बेक्लोमेथासोन लेबल, चेतावनियां और सावधानियां)

  • माइकोनाज़ोलएज़ोल एंटीफंगलमामूली

    There is no information regarding cross-hypersensitivity between miconazole and other azole antifungal agents. (माइकोनाज़ोल लेबल, चेतावनियां और सावधानियां)

  • मिथाइलएर्गोमेट्रिनएर्गोट एल्कलॉइडमामूली

    Examples of some of the strong CYP 3A4 inhibitors include saquinavir, grapefruit juice, nefazodone, macrolide antibiotics (e.g., troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). (मिथाइलएर्गोमेट्रिन लेबल, दवाओं के इंटरैक्शन)

  • मेट्रोनिडाज़ोलएंटीबायोटिकमामूली

    Fungal Superinfections Known or previously unrecognized candidiasis may present more prominent symptoms during therapy with LIKMEZ and requires treatment with an antifungal agent. (मेट्रोनिडाज़ोल लेबल, चेतावनियां और सावधानियां)

  • मोमेटासोनकॉर्टिकोस्टेरॉइडमामूली

    If oropharyngeal candidiasis develops, treat with appropriate local or systemic (i.e., oral) antifungal therapy while remaining on treatment with ASMANEX HFA therapy, but at times therapy with ASMANEX HFA may need to be interrupted. (मोमेटासोन लेबल, चेतावनियां और सावधानियां)

  • रेपाग्लिनाइडमेग्लिटिनाइडमामूली

    Examples: Drugs that are known to inhibit CYP3A4 include antifungal agents (ketoconazole, itraconazole) and antibacterial agents (clarithromycin, erythromycin). (रेपाग्लिनाइड लेबल, दवाओं के इंटरैक्शन)

  • सिक्लेसोनाइडकॉर्टिकोस्टेरॉइडमामूली

    When such an infection occurs, treat it with appropriate local or systemic (i.e., oral antifungal) therapy and discontinue ALVESCO. (सिक्लेसोनाइड लेबल, चेतावनियां और सावधानियां)

कोई महत्वपूर्ण इंटरैक्शन नहीं बताया गया (1)

  • राल्टेग्राविरएंटीरेट्रोवायरलकोई इंटरैक्शन नहीं

    Based on these data, ISENTRESS is not expected to affect the pharmacokinetics of drugs that are substrates of these enzymes or P-glycoprotein (e.g., protease inhibitors, NNRTIs, opioid analgesics, statins, azole antifungals, proton pump inhibitors and anti-erectile dysfunction agents). (राल्टेग्राविर लेबल, दवाओं के इंटरैक्शन)

आप जो कुछ भी लेते हैं, उस सबके साथ इकोनाज़ोल को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।

चेकर में खोलें

यह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।